iOS app Android app

Dexpramipexole Lou Gehrigs

Setback In Treatment For Lou Gehrig's Disease

Reuters | Posted 03.05.2013 | Healthy Living

* Shares fall 2 percent * 2016 sales estimate for dexpramipexole was $350 mln * Biogen to continue studying ALS treatmen...